Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Comment by Ventura2020on Jan 11, 2024 6:08am
123 Views
Post# 35820824

RE:RE:RE:Tilray Brands - The Dales Report - Jan 10, 2024

RE:RE:RE:Tilray Brands - The Dales Report - Jan 10, 2024
DaveInCalgary wrote: Anthony Varrel did a great wrap up of Tilray starting at about 40 minutes.

Anthony did mention retail investors (shorts) (cockroaches) bringing up Irwins compensation. I hope one or two are smart enough to understand Anthony's commenting on that issue at about 43 minute mark.


Hearing Irwin discuss meeting at German Parliament holds much more strength about German Medical Cannabis for me than a number of others.

Lets Go Medical Legalization 

All these bashers on here need have a good listen(multiple times), re compensation, vegetables, Tilray and schedule III, Germany, 50 million revenue to 1 billion, beverages, Tilray infrastructure, Tilray future. etc..etc... 
Very good listen, Dave
<< Previous
Bullboard Posts
Next >>